Search
Close this search box.
Logo Asphalion

EVENT | 2nd BIOEQUIVALENCE WORKSHOP

The workshop will provide a platform for an exchange of views between industry, regulators and academia.

The workshop will provide a platform for an exchange of views between industry, regulators and academia.
April 25, 2023

Join our expert, Lidia Cánovas, at the 2nd Bioequivalence workshop that will take place in Brussels tomorrow!

While regional public consultations on the draft of the Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage Forms text take place, leading international experts will gather tomorrow for an exchange of topics at Medicines for Europe workshop.

Join Lidia in Brussels by sending an email at: info@asphalion.com and do not hesitate reaching out to Asphalion for any regulatory need!

Event Info

a

Search News & Events

  • Filter by category

Share

Related news and events

IZABELA BEDZIAK | NEW ASSOCIATE DIRECTOR

At Asphalion we are proud to announce that Izabela Bedziak is now Scientific & Regulatory Affairs Associate Director!! Izabela has a BC and a Master’s Degree in Pharmacy from

CTIS applicable | Faster Access to Clinical Trial Information in Europe

CTIS is the single-entry point for the submission and assessment of clinical trial applications in the EU. It features a public, searchable database aimed at delivering a high level of transparency. The authorisation and oversight of clinical trials are managed by EU/EEA Member States, while the EMA maintains the CTIS. The European Commission oversees the implementation of the Clinical Trials Regulation.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting